Altered expression of Insulin receptor isoforms in breast cancer

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Huang, Jiaqi ^a   Morehouse, Chris ^a   Streicher, Katie ^a   Higgs, Brandon W ^a   Gao, Jin ^a   Czapiga, Meggan ^a   Boutrin, Anmarie ^a   Zhu, Wei ^a   Brohawn, Philip ^a   Chang, Yong ^a   Viner, Jaye ^a   LaVallee, Theresa ^a   Richman, Laura ^a   Jallal, Bahija ^a   Yao, Yihong ^a  

^a MEDIMMUNE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN RECEPTOR; INSULIN RECEPTOR A; INSULIN RECEPTOR B; MESSENGER RNA; UNCLASSIFIED DRUG; INSR PROTEIN, HUMAN; ISOPROTEIN; LEUKOCYTE ANTIGEN; SOMATOMEDIN C; TUMOR MARKER;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER TISSUE; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TUMOR GENE; BREAST TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY;

ANTIGENS, CD; BREAST NEOPLASMS; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INSULIN-LIKE GROWTH FACTOR I; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN ISOFORMS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, INSULIN; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 80055026624     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026177     Document Type: Article

References (33)

1. Seino S, Seino M, Nishi S, Bell GI, (1989) Structure of the human insulin receptor gene and characterization of its promoter. Proc Natl Acad Sci U S A 86 (1): 114-8.
2. Moller DE, Yokota A, Caro JF, Flier JS, (1989) Tissue-specific expression of two alternatively spliced insulin receptor mRNAs in man. Mol Endocrinol 3 (8): 1263-9.
3. Frasca F, Pandini G, Scalia P, Sciacca L, Mineo R, et al. (1999) Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells. Mol Cell Biol 19 (5): 3278-88.
4. Mosthaf L, Vogt B, Haring HU, Ullrich A, (1991) Altered expression of insulin receptor types A and B in the skeletal muscle of non-insulin-dependent diabetes mellitus patients. Proc Natl Acad Sci U S A 88 (11): 4728-30.
5. Sesti G, Marini MA, Tullio AN, Montemurro A, Borboni P, et al. (1991) Altered expression of the two naturally occurring human insulin receptor variants in isolated adipocytes of non-insulin-dependent diabetes mellitus patients. Biochem Biophys Res Commun 181 (3): 1419-24.
6. Kellerer M, Sesti G, Seffer E, Obermaier-Kusser B, Pongratz DE, et al. (1993) Altered pattern of insulin receptor isotypes in skeletal muscle membranes of type 2 (non-insulin-dependent) diabetic subjects. Diabetologia 36 (7): 628-32.
7. Pandini G, Vigneri R, Costantino A, Frasca F, Ippolito A, et al. (1999) Insulin and insulin-like growth factor-I (IGF-I) receptor overexpression in breast cancers leads to insulin/IGF-I hybrid receptor overexpression: Evidence for a second mechanism of IGF-I signaling. Clin Cancer Res 5 (7): 1935-44.
8. Vella V, Sciacca L, Pandini G, Mineo R, Squatrito S, et al. (2001) The IGF system in thyroid cancer: New concepts. Mol Pathol 54 (3): 121-4.
9. Pandini G, Medico E, Conte E, Sciacca L, Vigneri R, et al. (2003) Differential gene expression induced by insulin and insulin-like growth factor-II through the insulin receptor isoform A. J Biol Chem 278 (43): 42178-89.
10. Haring HU, Kellerer M, Mosthaf L, (1994) Modulation of insulin receptor signalling: Significance of altered receptor isoform patterns and mechanism of hyperglycaemia-induced receptor modulation. Diabetologia 37 (Suppl 2): S149-54.
11. Soos MA, Siddle K, (1989) Immunological relationships between receptors for insulin and insulin-like growth factor I. Evidence for structural heterogeneity of insulin-like growth factor I receptors involving hybrids with insulin receptors. Biochem J 263 (2): 553-63.
12. Pollak M, (2008) Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer 8 (12): 915-28.
13. Soos MA, Nave BT, Siddle K, (1993) Immunological studies of type I IGF receptors and insulin receptors: Characterization of hybrid and atypical receptor subtypes. Adv Exp Med Biol 343: 145-57.
14. Soos MA, Whittaker J, Lammers R, Ullrich A, Siddle K, (1990) Receptors for insulin and insulin-like growth factor-I can form hybrid dimers. characterization of hybrid receptors in transfected cells. Biochem J 270 (2): 383-90.
15. Ulanet DB, Ludwig DL, Kahn CR, Hanahan D, (2010) Insulin receptor functionally enhances multistage tumor progression and conveys intrinsic resistance to IGF-1R targeted therapy. Proc Natl Acad Sci U S A 107 (24): 10791-8.
16. Gao J, Chesebrough JW, Cartlidge SA, Ricketts SA, Incognito L, et al. (2011) Dual IGF-I/II-neutralizing antibody MEDI-573 potently inhibits IGF signaling and tumor growth. Cancer Res 71 (3): 1029-40.
17. Weigelt B, Mackay A, A'hern R, Natrajan R, Tan DS, et al. (2010) Breast cancer molecular profiling with single sample predictors: A retrospective analysis. Lancet Oncol 11 (4): 339-49.
18. Paik S, Shak S, Tang G, Kim C, Baker J, et al. (2004) A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351 (27): 2817-26.
19. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, et al. (2000) Molecular portraits of human breast tumours. Nature 406 (6797): 747-52.
20. Sotiriou C, Pusztai L, (2009) Gene-expression signatures in breast cancer. N Engl J Med 360 (8): 790-800.
21. Marcom PK, Isaacs C, Harris L, Wong ZW, Kommarreddy A, et al. (2007) The combination of letrozole and trastuzumab as first or second-line biological therapy produces durable responses in a subset of HER2 positive and ER positive advanced breast cancers. Breast Cancer Res Treat 102 (1): 43-9.
22. Creighton CJ, Casa A, Lazard Z, Huang S, Tsimelzon A, et al. (2008) Insulin-like growth factor-I activates gene transcription programs strongly associated with poor breast cancer prognosis. J Clin Oncol 26 (25): 4078-85.
23. Belfiore A, Pandini G, Vella V, Squatrito S, Vigneri R, (1999) Insulin/IGF-I hybrid receptors play a major role in IGF-I signaling in thyroid cancer. Biochimie 81 (4): 403-7.
24. Jones HE, Gee JM, Barrow D, Tonge D, Holloway B, et al. (2006) Inhibition of insulin receptor isoform-A signalling restores sensitivity to gefitinib in previously de novo resistant colon cancer cells. Br J Cancer 95 (2): 172-80.
25. van 't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, et al. (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415 (6871): 530-6.
26. Parker JS, Mullins M, Cheang MC, Leung S, Voduc D, et al. (2009) Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol 27 (8): 1160-7.
27. Fan C, Oh DS, Wessels L, Weigelt B, Nuyten DS, et al. (2006) Concordance among gene-expression-based predictors for breast cancer. N Engl J Med 355 (6): 560-9.
28. Oh DS, Troester MA, Usary J, Hu Z, He X, et al. (2006) Estrogen-regulated genes predict survival in hormone receptor-positive breast cancers. J Clin Oncol 24 (11): 1656-64.
29. Cheang MC, Chia SK, Voduc D, Gao D, Leung S, et al. (2009) Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer. J Natl Cancer Inst 101 (10): 736-50.
30. Papa V, Pezzino V, Costantino A, Belfiore A, Giuffrida D, et al. (1990) Elevated insulin receptor content in human breast cancer. J Clin Invest 86 (5): 1503-10.
31. Milazzo G, Giorgino F, Damante G, Sung C, Stampfer MR, et al. (1992) Insulin receptor expression and function in human breast cancer cell lines. Cancer Res 52: 3924-3930.
32. Vella V, Pandini G, Sciacca L, Mineo R, Vigneri R, et al. (2002) A novel autocrine loop involving IGF-II and the insulin receptor isoform-A stimulates growth of thyroid cancer. J Clin Endocrin Metab 87: 245-254.
33. Malaguarnera R, Frasca F, Garozzo A, Giani F, Pandini G, et al. (2001) Insulin receptor isoforms and insulin-like growth factor receptor in human follicular cell precursors from papillary thyroid cancer and normal thyroid. J Clin Endocrin Metab 96: 766-774.